Lv3
346 积分 2025-07-02 加入
Activity of PROTAC MDM2 degrader in primary leukemia cells and PDX models
1个月前
已完结
Discovery of a selective CDK7 PROTAC against acute leukemia with low platelet toxicity
1个月前
已完结
Discovery of a Potent RXRγ Degrader WCF-598 for the Treatment of Castration-Resistant Prostate Cancer
1个月前
已完结
Harnessing reactive oxygen species for precision medicine: ROS-Activatable PROTACs for lung Cancer
1个月前
已完结
G4‐Ligand‐Directed PROTACs Unveil DR1 as a Novel Ligand‐Co‐Binding G4‐Protein and Reshape G4‐Dependent Transcription
1个月前
已完结
Abstract PR008: Preclinical activity of an orally bioavailable PROTAC pan-KRAS degrader versus inhibitors in mutant KRAS models
1个月前
已完结
Modular Vinyl Phosphonamidates for Cysteine-Directed Protein Targeting
2个月前
已完结
Abstract B046: AZD9750, a novel androgen receptor proteolysis targeting chimera (AR-PROTAC) with monotherapy and combination activity in prostate cancer
2个月前
已关闭
Inhibition of mTOR Enhances the Efficacy of Proteasome-Dependent Targeted Protein Degradation Approaches
4个月前
已完结
Mode of action of a DCAF16-recruiting targeted glue that can selectively degrade BRD9
5个月前
已完结
皖公网安备34019202002308
